November 03, 2025

Metastatic ER-Positive, HER2-Negative Breast Cancer: Novel Treatment Combination Improves Progression-Free Survival

Patients with ER-positive, HER2-negative advanced breast cancer showed significantly improved progression-free survival (PFS) when treated with an oral combination regimen that includes giredestrant, ...

The ASCO Post

October 31, 2025

A Young Hematologist’s Take on ICML 2025

The ASCO Post

October 31, 2025

Addition of Brentuximab Vedotin to Lenalidomide/Rituximab in Relapsed or Refractory DLBCL

The ASCO Post

November 10, 2025

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

The ASCO Post

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

The ASCO Post

October 30, 2025

Digital Histopathology and Automated Classification of Pediatric Sarcomas

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

January 14, 2026

Two Heads Are Better Than One: Second Opinions and Collaborations in Oncology

JADPRO

January 14, 2026

Empowering Research Leadership: Development of an Intensive Course to Support Oncology Advanced Practitioner Participation in Clinical Trials

JADPRO

January 13, 2026

UCI Health Chao Family Comprehensive Cancer Center among the nation’s best

UCI Health

January 13, 2026

Clinical trial tests promising CAR T-cell therapy for lupus

UCI Health

January 13, 2026

Study links cannabis dependence to increased risk of urologic cancers

UCI Health

January 09, 2026

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

JADPRO

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

Royal College of Psychiatrists (RCPsych) International Congress

January 15, 2026

How Treatment Is Given May Matter Most

Conexiant

ASH 2025

January 08, 2026

CD123-Targeting ADC Shows Activity in AML and BPDCN

The ASCO Post

January 08, 2026

Non–Total Body Irradiation Conditioning Regimen for Young Patients With MRD-Negative B-ALL

The ASCO Post

December 22, 2025

Noninferiority Shown for Pirtobrutinib vs Ibrutinib in CLL/SLL

The ASCO Post

2025 ASCO GI

January 07, 2026

ChatGPT Has Limitations in Clinical Utility for Colorectal Cancer but May Be Useful for Patient Education

The ASCO Post

February 13, 2025

Triplet Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer

The ASCO Post

June 27, 2025

In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers

The ASCO Post

Clinical Guidelines

January 14, 2026

Empowering Research Leadership: Development of an Intensive Course to Support Oncology Advanced Practitioner Participation in Clinical Trials

JADPRO

January 09, 2026

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

JADPRO

January 09, 2026

Clinical Posters From JADPRO Live 2025

JADPRO

January 09, 2026

Flipped Nivolumab/Ipilimumab Dosing Improves Responses, Survival, and Safety in Advanced Melanoma

The ASCO Post

Commentary & Perspectives

January 09, 2026

Narrative Medicine: A Clinical Tool for the Oncology Advanced Practitioner

JADPRO

December 19, 2025

Integrating Mental Health Into Cancer Care: A Community Oncology Imperative

The ASCO Post

July 10, 2023

Expert Point of View: Pamela L. Kunz, MD and Corrie Marijnen, MD, PhD

The ASCO Post

January 25, 2023

Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

The ASCO Post

FDA & Government News

December 18, 2025

FDA Approves Amivantamab and Hyaluronidase-lpuj for Subcutaneous Injection

The ASCO Post

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

February 21, 2024

FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma

The ASCO Post

Business Management

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

Digital Histopathology and Automated Classification of Pediatric Sarcomas

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

Royal College of Psychiatrists (RCPsych) International Congress

ASH 2025

2025 ASCO GI

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management